# Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study

> **NCT02275260** · NA · TERMINATED · sponsor: **Biotronik SE & Co. KG** · enrollment: 110 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** Cerebral Diffusion-Weighted Magnetic Resonance Imaging
- **DEVICE:** Transesophageal Echocardiography
- **OTHER:** Paperbased neurocognitive testing

## Key facts

- **NCT ID:** NCT02275260
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2017-02-08
- **Final completion:** 2018-02-15
- **Target enrollment:** 110 (ACTUAL)
- **Why stopped:** The required number of endpoints will be obtained with a sample size lower than initially planned.
- **Last updated:** 2019-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02275260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02275260, "Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02275260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*